12525Army Medical University, China.
Nurs Ethics. 2021 Jun;28(4):554-562. doi: 10.1177/0969733020952114. Epub 2020 Oct 16.
China's ethics committees alone are unable to meet the growing need for human participant protection. Several scandals in recent years indicate weaknesses in the protection of human participants in China.
The aim of the study is to summarize the status and problems of human research protection program in China and to explore its establishment proposals at national and hospital levels.
To conduct literature retrieval, Chinese National Knowledge Infrastructure, Chinese Biomedical Document Database, and English databases Web of Science and PubMed were searched; laws, guidelines, and regulations were also searched on web by Google and Chinese search engine Baidu.
No data were collected from human participants, and ethical review was not required.
There are problems for China's Human Research Protection Program, such as weak relevant legal systems, insufficient administrative supervision, and incompetent ethics committee capacities. To fully protect human participants, China should promote the development of Human Research Protection Program, which can formulate ethics-related laws, improve regulations for the protection of the safety and rights of human participants, strengthen supervision, and enforce compensation for human participants. Owing to the frequency with which human participants are recruited in hospitals in China, hospitals can utilize existing ethics committees and establish data and safety monitoring committees, quality control, fund and contract management, and conflict of interest management offices.
As a growing program, it remains necessary to learn from the experience of developed countries with high ethics standards and reformulate them to fit China's conditions to explore potential future development. The program will also be an experience for other developing countries.
Human Research Protection Program can strengthen communication and coordination among various hospital departments to effectively protect the rights and welfare of human participants.
中国的伦理委员会单独运作已无法满足日益增长的保护人类参与者的需求。近年来的几起丑闻表明,中国在保护人类参与者方面存在缺陷。
本研究旨在总结中国人类研究保护计划的现状和问题,并探讨在国家和医院层面建立该计划的建议。
通过文献检索,检索了中国国家知识基础设施、中国生物医学文献数据库以及英文数据库 Web of Science 和 PubMed;并通过 Google 和中国搜索引擎百度在网络上检索相关法律法规、指南和规定。
本研究未从人类参与者处收集数据,因此不需要伦理审查。
中国的人类研究保护计划存在一些问题,例如相关法律体系薄弱、行政监督不足以及伦理委员会能力不足。为了充分保护人类参与者,中国应促进人类研究保护计划的发展,该计划可以制定与伦理相关的法律,完善保护人类参与者安全和权益的规定,加强监督,并对人类参与者进行赔偿。鉴于中国医院招募人类参与者的频率较高,医院可以利用现有的伦理委员会,并建立数据和安全监测委员会、质量控制、资金和合同管理以及利益冲突管理办公室。
作为一个不断发展的计划,有必要借鉴具有高标准伦理的发达国家的经验,并对其进行改革以适应中国国情,探索潜在的未来发展。该计划也将为其他发展中国家提供经验。
人类研究保护计划可以加强各医院部门之间的沟通和协调,有效保护人类参与者的权利和福利。